ILMN logo

ILMNIllumina Inc

$165.30
$2.34
(1.44%)
Today
Updated: 03:33 PM EDT
EarningsJul 30
Mkt Cap$24.66B
Vol1.38M
News
all
press releases
Is QGEN Stock a Hold After the 2026 Outlook Cut and Q1 Miss?
QIAGEN cuts its 2026 growth outlook after a Q1 miss, but margins, cash flow and a debt-free balance sheet could steady the narrative.
Zacks
News Placeholder
More News
News Placeholder
Illumina and SPT Labtech unveil fireflyGO, enabling faster, simpler targeted oncology research
Illumina and SPT Labtech unveil fireflyGO, enabling faster, simpler targeted oncology research Illumina and SPT Labtech unveil fireflyGO, enabling faster, simpler targeted oncology research PR Newswire SAN DIEGO, May 28, 2026 Automating library prep reduces hands-on time for customers using Pillar...
PR Newswire
News Placeholder
QIAGEN Business Breakdown and Growth Drivers for 2026
QGEN targets steadier growth through 2027, leaning on new launches, Connect automation and QIAstat-Dx menu expansion amid choppy demand.
Zacks
News Placeholder
Illumina introduces the first distributed whole-genome sequencing solution for highly sensitive MRD research
Illumina introduces the first distributed whole-genome sequencing solution for highly sensitive MRD research Illumina introduces the first distributed whole-genome sequencing solution for highly sensitive MRD research PR Newswire SAN DIEGO, May 28, 2026 An advanced research workflow for fast...
PR Newswire
News Placeholder
Here's Why Illumina (ILMN) is a Strong Momentum Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Zacks
News Placeholder
Illumina (ILMN) is a Top-Ranked Growth Stock: Should You Buy?
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Zacks
News Placeholder
David P. King elected to Illumina's Board of Directors
David P. King elected to Illumina's Board of Directors David P. King elected to Illumina's Board of Directors PR Newswire SAN DIEGO, May 21, 2026 Former Labcorp Chairman and CEO brings deep healthcare, diagnostics, and clinical expertise to Illumina's BoardSAN DIEGO, May 21, 2026 /PRNewswire...
PR Newswire
News Placeholder
Is This the Right Time to Retain ILMN Stock in Your Portfolio?
Illumina advances its sequencing strategy with strong NovaSeq X momentum and clinical demand, but China's weakness and macro pressures cloud the outlook.
Zacks
News Placeholder
Illumina releases 2025 Corporate Responsibility Report, expanding access to genomics and accelerating global impact
Illumina releases 2025 Corporate Responsibility Report, expanding access to genomics and accelerating global impact Illumina releases 2025 Corporate Responsibility Report, expanding access to genomics and accelerating global impact PR Newswire SAN DIEGO, May 19, 2026 SAN DIEGO, May 19, 2026...
PR Newswire
News Placeholder
Here Are Thursday's Top Wall Street Analyst Research Calls: Commercial Metals, Doximity, Draftkings, Hut 8, Illumina, Lowe's, TeraWulf, Starbucks, Whirlpool, Wix.com, and More
Here Are Thursday's Top Wall Street Analyst Research Calls: Commercial Metals, Doximity, Draftkings, Hut 8, Illumina, Lowe's, TeraWulf, Starbucks, Whirlpool, Wix.com, and More...
Yahoo! Finance: News
<
1
2
...
>